May 7, 2020
Oligomerix appoints ex Pfizer executive, as Chief Financial Officer
Oligomerix, Inc., a privately held company focused on therapeutics targeting tau for Alzheimer’s disease similar dementias, which is also currently seeking strategic partners to support the acceleration and advancement of those programs, has appointed Robert Foerster as Chief Financial Officer.